Horstmeier Paul's Form 4 filing
Health Catalyst, Inc. (HCAT) · filed Dec 7, 2021
- Accession no.
- 0001562180-21-007528
- Filed
- Dec 7, 2021
- Trade date
- Dec 2-6, 2021
- Filing delay
- 5 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions. Open-market sales total $237.7K. It was filed 5 days after the trade, past the 2-business-day deadline.
This filing was later replaced by the amendment 0001562180-21-007900 (Dec 29, 2021). Trade tables on this site use the amended version.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Horstmeier PaulCIK 0001780978 | Officer (Chief Operating Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 2, 2021 | Common Stock | FTax withholdingDisposed | −9,261 | $41.95F2 | −$388,498.95 | 99,180 | Direct | |
| Dec 6, 2021 | Common Stock | SSaleDisposed | −600 | $37.97F4 | −$22,782 | 98,580 | Direct | |
| Dec 6, 2021 | Common Stock | SSaleDisposed | −2,674 | $38.76F5 | −$103,644.24 | 95,906 | Direct | |
| Dec 6, 2021 | Common Stock | SSaleDisposed | −2,789 | $39.89F6 | −$111,253.21 | 93,117 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Represents a weighted average price reported by the broker. These shares were sold as part of a block trade in multiple transactions at prices ranging from $40.33 to $42.76, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote with regard to the block trade.
Referenced by the price of 1 transaction in Table I.
- F4
Represents the weighted average sale price of the shares sold ranging from $37.47 to $38.43 per share, inclusive.
Referenced by the price of 1 transaction in Table I.
- F5
Represents the weighted average sale price of the shares sold ranging from $38.47 to $39.24 per share, inclusive.
Referenced by the price of 1 transaction in Table I.
- F6
Represents the weighted average sale price of the shares sold ranging from $39.66 to $40.22 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (4) through (6).
Referenced by the price of 1 transaction in Table I.